Olema Pharmaceuticals, Inc. (OLMA) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bvf Partners L P/Il entity

Director

$44.14M (11)

—

+$44.14M

547,082

0.6253%

$6.41M

—

Paradigm Biocapital Advisors LP entity

10% owner

$1.16M (1)

$35.80M (2)

−$34.64M

783,118

0.8950%

$9.17M

−74.6%

G. Walmsley Graham

Director

$33.64M (6)

$22.18M (3)

+$11.46M

2,568,875

2.94%

$30.09M

+237.3%

Cormorant Asset Management, LP entity

Former 10% Owner

$8.08M (1)

—

+$8.08M

3,270,544

3.74%

$38.31M

—

Naseem Zojwalla

Chief Medical Officer

—

$7.99M (10) scheduled

−$7.99M

4,488

0.0051%

$52.57K

−80.7%

Ian T Clark

Director

—

$7.87M (3) scheduled

−$7.87M

0

0.0000%

$0.00

—

Cyrus Harmon

Director

—

$6.37M (50)

−$6.37M

941,826

1.08%

$11.03M

−8.2%

David C. Myles

Ch. Discov. & Non-Clin Dev Off

—

$5.61M (20) scheduled

−$5.61M

842,453

0.9628%

$9.87M

+38.8%

Shane William Charles Kovacs

Ch. Operating & Financial Off.

— (2)

$3.57M (8)

−$3.57M

139,727

0.1597%

$1.64M

+644.4%

Kinney Horn

Chief Business Officer

—

$2.98M (16) scheduled

−$2.98M

2,458

0.0028%

$28.79K

0.0%

Sean Bohen

President and CEO

—

$2.11M (12)

−$2.11M

237,650

0.2716%

$2.78M

+806.1%

Bain Capital Life Sciences Investors, LLC entity

10% owner

$1.73M (1)

—

+$1.73M

4,300,000

4.91%

$50.37M

−42.7%

Shawnte Mitchell

Chief Legal Officer

—

$951.50K (3) scheduled

−$951.50K

0

0.0000%

$0.00

—

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

1,725,406

1.97%

$20.21M

—

Peter J. Kushner

Chief Scientific Officer

—

1,431,672

1.64%

$16.77M

+54.1%

Andrew Rappaport

Director

—

866,979

0.9909%

$10.16M

+68.8%

Frank McCormick

Director

—

275,373

0.3147%

$3.23M

+390.4%

Cynthia M Butitta

Director

—

83,876

0.0959%

$982.52K

—

Sasha Lu Austin

VP of Finance and Controller

—

16,188

0.0185%

$189.63K

+260.7%

Olema Pharmaceuticals, Inc.

What the insiders did Net buying

By person